Business

UK-RTC Statement

UK-RTC Statement.

articleCambridge Nutritional Sciences PlcNovember 12, 20203/company/cambridge-nutritional-sciences-plc/news/uk-rtc-statement
UK-RTC Statement

About this update from Cambridge Nutritional Sciences Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 1791F\n Omega Diagnostics Group PLC\n 12 November 2020\n  \n \n \n \n OMEGA DIAGNOSTICS GROUP PLC \n \n \n (\"Omega\" or the \"Company\" or the \"Group\")\n \n \n  \n \n \n UK-RTC Statement\n \n \n  \n \n \n Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes \n \n \n the press release issued today by the UK Rapid Test Consortium (\"UK-RTC\"), of which Omega is a partner, surrounding the \n recent press speculation on the AbC-19 Rapid Test and the data provided in the BMJ report.\n \n \n  \n \n \n The UK-RTC believes the press articles and related BMJ report puts a spotlight on the different types of antibody testing available and what their applications are, and the UK-RTC welcomes this.  However, the UK-RTC has concerns with the \n BMJ research report and modelling methodology the full details of which are provided below.  \n \n \n  \n \n \n The statement confirms that DHSC is satisfied with the performance of the test, as is the UK-RTC, and will continue to roll out the use of the product. Public Health England conducted an evaluation at the DHSC's request, prior to DHSC purchasing the product, and will continue to deploy the test for use in surveillance studies.  \n \n \n  \n \n \n The UK-RTC statement is reproduced in full at the end of the statement and can be found here: \n \n \n \n \n https://www.abingdonhealth.com/abc-19-response-to-media/\n \n \n  \n \n \n  \n \n \n Contacts: \n \n \n  \n \n \n \n \n \n Omega Diagnostics Group PLC  \n \n \n \n \n Tel: 01259 763 030\n \n \n \n \n \n \n Bill Rhodes, Interim Non-Executive Chairman \n \n \n Colin King, Chief Executive  \n \n \n \n \n \n \n www.omegadiagnostics.com\n \n \n \n \n \n \n \n \n Kieron Harbinson, Group Finance Director\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n finnCap Ltd\n \n   \n \n \n \n \n Tel: 020 7220 0500\n \n \n \n \n \n \n Geoff Nash/Edward Whiley (Corporate Finance)\n \n \n \n \n \n \n \n \n \n \n \n \n \n Alice Lane (ECM)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n Tel: 020 7933 8780 or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McMa...

More updates from Cambridge Nutritional Sciences Plc